Accessibility
Executive Committee
- Pedro de Godoy Bueno Chief Executive Officer
- Lício Tavares Ângelo Cintra Chief Operations Officer
- André Covre Chief Financial Officer
- Danilo Ricardo Bono Zimmermann Information Technology, Security & Data Protection Officer
- Emerson Leandro Gasparetto Hospital Operations & Oncology Officer
- Fabio Rosé People & Culture Officer
- Leonardo Modesti Vedolin Medical Officer
- Rafael Lucchesi Outpatient & Diagnostics Officer
- Nelcina Conceição de Oliveira Legal, Compliance, ESG, Public Relations and Internal Audit Director
- Rafael Sampaio da Motta Commercial Director
- Helisson Brígido Andrade Lemos Product, Marketing, Analytics and Customer Experience Officer (PMAX)
- Glauco Desiderio Investor Relations Officer
- Linaldo Vilar Junior Production Officer
Pedro was elected the Company’s Chief Executive Officer in December 2014. Previously he served at Credit Suisse, Banco BTG Pactual, and Amil.
Mr. Bueno holds a degree in economics from the Pontifical Catholic University of Rio de Janeiro (PUC-RJ).
Currently, he is a partner of DNA Capital, a healthcare private equity firm.
On June 27, 2023, Lício Tavares Ângelo Cintra was elected by the Board of Directors to hold the position of Chief Operations Officer until January 31, 2024, as part of the succession plan of the current CEO of the Company.
Before joining DASA, he was a member of the Board of Directors and Vice President – M&A and Commercial at Hapvida, besides working for 14 years at Grupo São Franciso, 10 years as head of the Group.
Lício holds a degree in Electrical Engineering from Universidade Presbiteriana Mackenzie, has completed a specialization program in Business Administration from FGV and holds an MBA in Controllership and Finance from USP (FUNDACE) and an International Executive MBA from FIA.
Mr. Andre Covre was elected on August 24, 2023, by the Board of Directors to the position of Chief Financial Officer.
Before joining DASA, he worked for 15 years at the Ultra Group, as Chief Financial and Investor Relations Officer and CEO of Extrafarma. He has also worked for multinational companies such as Unisys Corporation in the United States and ABN AMRO Capital in Europe.
Andre has a degree in Public Administration from Fundação Getúlio Vargas and an MBA from INSEAD.
Danilo has been the Company’s Information Security & Data Protection Officer since October 2020.
Before joining the Company, Danilo worked in the IT department of several companies, such as Orbitall, Redecard, Global Payments, Qualicorp, Alelo, and Cielo. He was a member of Cielo S.A.’s board of directors between 2019 and 2020.
Danilo holds a degree in computer engineering from the Federal University of São Carlos in 1997, with graduate studies in business administration from Mauá Institute of Technology in 2000.
Emerson was elected for the position of Hospital Operations & Oncology Officer in April 2019. Emerson is a neuro-radiologist and managing physician at Clínica de Diagnóstico por Imagem (CDPI), Rio de Janeiro, a company merged into Dasa in 2014.
Emerson holds a degree in medicine from the Federal University of Paraná, a master’s degree and a Ph.D. from the Federal University of Rio de Janeiro, and also holds a Research Fellowship from the University of Pennsylvania.
Mr. Gasparetto also concluded the specialization in Health Services Management and an Executive MBA from COPPEAD – Federal University of Rio de Janeiro.
Fabio was elected for the position of People & Culture Officer in January 2021.
With 20-year professional experience, Mr. Rosé worked for companies, such as BankBoston, and Novartis; his most recent position was human resources senior vice president at L’Oréal Luxe, New York.
Fabio holds a degree in pedagogy from Anhembi Morumbi University, with human resources specialization courses (Getúlio Vargas Foundation), marketing (ESPM), executive master’s degree in coaching, and change management from INSEAD, France.
Leonardo was elected for the position of Dasa’s medical officer in 2017. Previously, Leonardo served as a neuro-radiology medical officer and coordinator at the Company.
Before joining Dasa, Leonardo served as a founding partner at Medvia Diagnóstico, and chief of radiology services at Clinics Hospital in Porto Alegre.
Leonardo holds a Ph.D. in medical sciences from the Federal University of Rio Grande do Sul (UFRGS). He holds a degree in medicine from PUCRS, with graduate studies in neuro-radiology from Mount Sinai School of Medicine and graduate studies in vascular neurology from Massachusetts General Hospital.
Mrs. Tropardi was elected on 10/17/2022 by the Board of Directors Legal, Compliance, ESG, Public Relations and Internal Audit Director.
Before joining the Company, she served as Chairwoman of the 6th Chamber of the Ethics Council of Advertisement Self-Regulation Brazilian Council (CONAR) between 2016 and 2022; between 2019 and 2022, Mrs. Tropardi also held the office of National Executive Board President of Advertisers Brazilian Association (ABA).
She holds a degree and graduate studies in Law from the University of São Paulo (USP), with an MBA in Business Administration from Dom Cabral Foundation.
Mr. Rafael Sampaio da Motta was elected on September 30, 2022 to occupy the position of Chief Commercial Officer.
Since November 2021 he has held the position of Managing Director and Head of Dasa Empresas, one of the verticals of the Company’s Ecosystem.
Between 2018 and 2022 and between 2005 and 2022 he served, respectively, as founding partner of Itech Care and as CEO of Grupo Case Benefícios de Seguros, companies acquired and belonging to the Company’s Ecosystem.
Mr. Rafael Sampaio da Motta holds a degree in Business Administration from Escola Superior de Propaganda e Marketing, an OPM in Management, Business and Marketing from Harvard Business School and a post-graduate degree in Marketing from Escola Superior de Propaganda e Marketing.
Helisson Brígido Andrade Lemos was elected on May 15, 2023 to serve as Products, Marketing, Analytics and Customer Experience (PMAX) Officer.
Worked for more than 17 years in Mercado Livre (NASDAQ: MELI), a leading retailer and provider of digital financial services in Latin America, reaching the position of Country General Manager, responsible for the group’s operational and financial results in Brazil.
As COO of Movile, was coresponsible for creating governance and acceleration of the group’s technology investees.
More recently, he was VP of Digital Innovation at VIA (B3: VIIA3), responsible for kicking off the Company’s digital transformation and contributing to one of the greatest turnarounds in Brazilian retail. He is also an investor and serves on the boards of human resources, technology and educational companies.
Mr. Lemos holds a degree in business administration from the Fundação Getúlio Vargas, an MBA from Escola Superior de Propaganda e Marketing and an Executive MBA from the Stanford Graduate School of Business.
Glauco was elected on June 6, 2022 by the Board of Directors to serve as Investor Relations Officer.
Before joining the Company, he worked at GNDI as Investor Relations Officer from 2017 to 2022, as financial corporate manager at COSAN and as investor relations and business development officer at Netshoes, as well as a member of the Board of Directors of Ideation Brasil.
He has experience in the private sector in logistics, energy, technology and consulting in Brazil, working in the financial, business development, investor relations and treasury areas, responsible for corporate finance, financial planning, merger and acquisitions, financial structuring operations, relations with private equity funds and investment banking.
Glauco holds a B.A. in Business Administration from Fundação Armando Álvares Penteado (FAAP), as well as an MBA in Finance from Fundação Getúlio Vargas (FGV).
Linaldo was elected on July 25, 2016 by the Board of Directors to serve as Production Officer.
He has 25 years of experience in the Supply Chain area at companies such as Kenner, Giroflex-forma, Coca-Cola, Reckitt Benckiser, ABlnBev.
Linaldo holds a B.Sc. in Chemical Engineering from Catholic University of Pernambuco, an Executive MBA from Business School São Paulo and a Green Belt from Fundação Christiano Otonni. He also completed the Supply Chain Leadership Program from Georgia Tech, University of Georgia, USA.
Board of Directors
Dr. Dulce is co-chairwoman of Dasa’s board of directors. She dedicated her professional career to healthcare and hospital operations-related activities.
In 1971, Dr. Dulce co-founded Casa de Saúde São José, the inception of Grupo Amil. Dr. Dulce was controlling shareholder of Amil Assistência Médica Internacional, Ltda. founded in 1972, which became the largest health insurance provider and operator of various hospitals and clinics in Brazil. In 2012, this company was sold to UnitedHealth Group Inc., one of the USA’s leading healthcare companies.
Dr. Dulce also held the following positions: (i) co-founder and officer at Hospital SOMICOL, currently known as Hospital Mario Lioni, and the first pediatric intensive care unit in Latin America, from 1972 to 1984; (ii) superintendent at Amil Previdência Privada, insurance company, an arm of Grupo Amil, from 1984 to 1986; (iii) customer service officer at Amil, from 1986 to 1988; (iv) superintendent at ESHO – Empresa de Serviços Hospitalares S.A., a holding of 17 hospitals, from 1988 to 1990; (v) chairwoman of the boards of directors of Amil International Insurance Company, Inc. and Amil International (Texas), Inc., insurance companies, from 1996 to 2005; (vi) vice chairwoman of Amil Participações S.A.’s board of directors, from 2007 to 2012; (vii) chairwoman of the sustainability committee, from 2012 to 2013; and (viii) chairwoman of the boards of directors of Amil LifeSciences, from 2010 to 2014, and Excellion, from 2012 to 2014, both in the management of medical training companies and research.
Dr. Dulce holds a degree in medicine from the Federal University of Rio de Janeiro (UFRJ) in 1971. She holds the following titles at UFRJ: pediatric specialist in 1972, post-PhD in medicine (master’s degree) with specialization in pediatrics in 1976, and an MBA from COPPEAD in 1984. In 2000, she obtained a Ph.D. in business administration, with a specialization in health from the University of Texas, Austin. From 1973 to 1978, Dr. Dulce was an Assistant Professor in the Pediatrics Department of the Faculty of Medicine of the Catholic University of Petrópolis.
Currently, Romeu holds the positions of co-chairman of the board of directors and member of the Company’s audit committee.
Mr. Domingues served as scientific director at Colégio Brasileiro de Radiologia e Diagnóstico por Imagem; in 2011 he held the position of chief imaging officer at Dasa. In 2012, he held the position of Dasa’s chief executive officer.
Romeu holds a degree in medicine from the Federal University of Rio de Janeiro in 1986, with a medical residency in radiology and diagnostic imaging. He completed graduate studies from Harvard University, with a qualification in magnetic resonance imaging.
Dr. Oscar is vice chairman and independent member of Dasa’s board of directors.
Currently, Dr. Oscar is a member of the following boards of directors: (i) Localiza Rent a Car S.A.; (ii) Votorantim Participações; and (iii) Omini Brasil.
From 1999 to 2003, Oscar was chairman of TIW do Brasil’s board of directors, a Canadian telecommunications company; between 1996 and 1999, he was Bunge International’s chief executive officer, a global leader in agribusiness and food industries. Before joining Bunge, Oscar was senior vice-president and partner of Booz Allen & Hamilton, Latin America. Previously, he was the chief operations officer at Ferro Corporation, Brazil.
Dr. Oscar holds a degree in chemical engineering from the Federal University of Rio de Janeiro.
Dr. Henrique is a member of Dasa’s board of directors.
Dr. Henrique held the following positions: (i) orthopedic surgeon at Hospital Rede Esho 2002 – 2005-Amil Resgate Saúde’s CEO, from 2005 to 2015; (ii) medical supplies officer at Amil International Insurance/United Healthcare and 32 hospitals, from 2005 to 2013; (iii) he participated in IPO and Road Show of Amil International Insurance, in October 2007; and, (iv) Hospital das Américas’ CEO, Brazil’s largest private hospital at that time, from 2009 to 2014.
Dr. Henrique has been a member of Rede Ímpar’s board of directors, since 2013 and Grupo Dasa, since 2016; also Patrys Investimentos Imobiliários LTDA’s CEO.
Dr. Henrique holds a degree in medicine from UNIG, Rio de Janeiro, in 2002. He holds the following titles: (i) orthopedic surgery – Federal University of Rio de Janeiro (UNI-RIO) 2003 – 2005; (ii) Executive MBA in health – UFRJ – COPPEAD – 2006 – 2007; (iii) corporate governance in family companies – IBGC (Brazilian Institute of Corporate Governance) – 2007; (iv) corporate governance in health – IBGC (Brazilian Institute of Corporate Governance) – 2009; (v) Harvard Business School – OPM IV (Owner/President Management) – 2011.
Mr. Carlos holds a degree in Mechanical Engineering and Economics with honorable distinction from Stanford University and has been a partner at DNA Capital Consultoria since 2015.
Carlos joined Dasa in 2015 as CFO, an office he held until 2018 when he was elected as the Company’s CEO / Managing Director. In 2021, Carlos took office as Outpatient Care and Diagnostics Operations Officer, and in 2022, he left the Company’s Executive Board to become a member of Dasa’s Board of Directors.
Previously, he was a partner at Gávea Investimentos between 2008 and 2014, liable for investments in the health sector and other segments. From 2006 to 2008, he served as an associate member at Kohlberg Kravis Roberts & Co. (“KKR”), New York, participating in various private equity transactions. Carlos also worked at Morgan Stanley and JP Morgan over his career.
Mr. Stelleo is an independent board member of Dasa.
Mr. Stelleo holds a bachelor’s degree and a Master’s degree in Mechanical Engineering from Stanford University with an MBA from Stanford Graduate School of Business. Mr. Stelleo is advisor and co-founder of Mercado Libre (NASDAQ: MELI), Latin America’s leading retail and online financial services company, over the past 23 years, he led the Brazilian operation, as regional COO and e-commerce officer. Mr. Stelleo also acts as investor, board member, and mentor for IT, consumer, education and fintech segments.
Audit Committee
Mrs. Viviane Pinto Mendes holds the position of a member of the audit committee of Dasa and controllership manager at Signo Investimentos.
Her professional experience over the past five years includes Rede Impar and Signo Investimentos, companies in the health and investments sectors, respectively. Previously, she held the positions of internal controls manager, controller, member of the audit committee, and executive.
Currently, Romeu holds the positions of co-chairman of the board of directors and member of the Company’s audit committee.
Mr. Domingues served as scientific director at Colégio Brasileiro de Radiologia e Diagnóstico por Imagem; in 2011 he held the position of chief imaging officer at Dasa. In 2012, he held the position of Dasa’s chief executive officer.
Romeu holds a degree in medicine from the Federal University of Rio de Janeiro in 1986, with a medical residency in radiology and diagnostic imaging. He completed graduate studies from Harvard University, with a qualification in magnetic resonance imaging.
Mr. José Ronaldo Vilela Rezende is a member of the audit committee, with extensive experience in corporate accounting.
Over the past five years, Mr. José Ronaldo Vilela Rezende has been serving at PWC PricewaterhouseCoopers, an audit and advisory company, as a partner in charge of the Risk Assurance Service area.
The Internal Regulation of the Audit Committee was duly approved by the Company’s Board of Directors on May 13, 2021 and is available: (i) at the Company’s headquarters: Avenida Juruá, 434, Alphaville, CEP 06455-010, Barueri/SP; and (ii) on the Company’s website (www.dasa.com.br).